New Hemodynamic Insights in Pulmonary Vascular Disease and Heart Failure with Preserved Ejection Fraction

Simon Vanhentenrijk,Frederik H. Verbrugge
DOI: https://doi.org/10.1007/s11936-021-00900-x
2021-02-22
Current Treatment Options in Cardiovascular Medicine
Abstract:Patients often present with a mixed phenotype of pulmonary vascular disease and heart failure with preserved ejection fraction (HFpEF). Identifying the exact hemodynamic culprits in such cases has important therapeutic implications. This review discusses the hemodynamic characterization and treatment options in patients with pulmonary vascular disease, HFpEF, and their combination.
What problem does this paper attempt to address?